Emory University School of Medicine scientists have created a miniature model to simulate a mechanical injury to a small blood vessel and track the hemostatic process at the single-cell level. The microfluidics-based system allows researchers to observe the three mechanisms involved in bleeding at work together: blood vessel narrowing, platelet activity and clotting factor activity.
Researchers analyzed data for 498 leukemia patients with a median age of 6 for three influenza seasons from 2010 to 2013 and found that rates of influenza and influenza-like illness were the same with and without influenza vaccination. Hand hygiene and additional precautionary measures should be taken for leukemia patients, according to the study in the Journal of Pediatrics.
Including pharmacists in multidisciplinary health care teams improves HIV patients' adherence to antiretroviral therapy, according to a study published in the Journal of Managed Care and Specialty Pharmacy. Viral load decreased to undetectable levels in patients referred to a pharmacist-led ART adherence clinic, and the researchers estimated a 3-to-1 return on investment in avoided medical costs.
Astellas Pharma will pay $102.5 million upfront to acquire Seattle-based Universal Cells, the firm that developed the Universal Donor Cell technology, which produces cell therapy products that do not need human leukocyte antigen matching. The deal will also let Japan-based Astellas apply the technology to other diseases.
More must be done to prevent pandemic outbreaks of viruses, said Robert Glasser, outgoing head of the United Nations' Office for Disaster Risk Reduction. These new diseases can kill millions of people, he said.
Banyan Biomarkers' Brain Trauma Indicator is the first blood test to receive FDA approval to screen for a certain type of brain damage that is usually only detectable with CT scans. The test assesses levels of two proteins, UCH-L1 and GFAP, and it could reduce the need for unnecessary neuroimaging tests and radiation exposure.
AABB published the first issue of the newly redesigned AABB News, which focuses on patient blood management. The magazine features articles on how institutions are convincing physicians to embrace PBM using clinical evidence and empowerment strategies and how some champions met the challenges of bringing PBM into community, pediatric and teaching hospital settings. Other articles describe how blood centers responded to Hurricane Harvey and research presented at the 2017 AABB Annual Meeting.